MedPath

Study to evaluate the efficacy of Dhanyamla Dhara in Diabetic Neuropathy

Phase 1/2
Not yet recruiting
Conditions
Other disorders of peripheral nervous system. Ayurveda Condition: PRAMEHA-UPADRAVAH,
Registration Number
CTRI/2023/08/056952
Lead Sponsor
DR VAIDYANATH V.S
Brief Summary

*Dhanyamla* is a medicine which can be used as multifaceted treatment. It is *Jeevana* (sustainer of life), *Daha Nashana* (mitigate burning sensation), *Vata Kapha Nashaka* (pacify vata & kapha), *Trishna hara* (mitigate thirst), *Deepana* (enhance digestion), *Jarana* (digestive), *Sramahara* (relieves fatigue) and  *Klamahara* (relieves exhaustion).

 Since the symptoms of Diabetic Peripheral Neuropathy such as pain, burning sensation, numbness and tingling sensation can be correlated to the involvement of vitiated *Vata* and *Kapha, Dhanyamla*, having properties of *Vata Kapha nashaka, Dahahara, Trisnahara,* etc can be used for the treatment of Diabetic Peripheral Neuropathy. Hence*, Sarvanga dhara* by *Dhanyamla* in Diabetic Peripheral Neuropathy is choosen for this study.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria
  • 1.Metabolically stable diabetic subjects with symptomatic Diabetic Peripheral Neuropathy.
  • 2.Subjects of all gender between the age group of 30-65 years.
  • 3.Subjects fulfilling the diagnostic criteria.
  • 4.Subjects whose HbA1C is between 6.5 to 10%.
Exclusion Criteria
  • 1.Subjects where HbA1C >10% and <6.5%.
  • 2.Subjects suffering from Type-1 Diabetes or Gestational Diabetes.
  • 3.Pregnant and lactating women.
  • 4.Subjects suffering from infectious diseases and non-healing ulcer/ ulcers of foot.
  • 5.Any systemic illness that can interfere with the course of treatment.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Changes in Michigan Neuropathy Screening Instrument (MNSI) Questionnaire scoreBefore intervention 0th day | After intervention 7th day | Follow up 14th day
Assessment of the patients condition will be done based onBefore intervention 0th day | After intervention 7th day | Follow up 14th day
2.Changes in Toronto Neuropathy Clinical Scale (TCNS) ScoreBefore intervention 0th day | After intervention 7th day | Follow up 14th day
3.Changes in Visual Analog Scale (VAS)Before intervention 0th day | After intervention 7th day | Follow up 14th day
Secondary Outcome Measures
NameTimeMethod
1. Changes in FBS value2. Changes in PPBS value

Trial Locations

Locations (1)

Sri Sri College of Ayurvedic Science and Research Hospital Bangalore

🇮🇳

Bangalore, KARNATAKA, India

Sri Sri College of Ayurvedic Science and Research Hospital Bangalore
🇮🇳Bangalore, KARNATAKA, India
Dr Vaidyanath V S
Principal investigator
9495593392
drvaidyanathvs@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.